Ciba-Geigy’s Habitrol
Executive Summary
Canadian Patented Medicine Prices Review Board will hold a hearing on March 2 to consider whether Ciba-Geigy Canada Ltd. "is selling or has, while a patentee, sold [the Habitrol nicotine patch] in any market in Canada at a price that, in the board's opinion, is or was excessive and if so, what order, if any, should be made." A preheating conference has been scheduled for Jan. 18.